Table 3. Childhood BMI and the risk of endometrioid adenocarcinoma, following women from 1995 when HRT information was availablea.
Censoring for unopposed oestrogen use | Age (years) | N | Cases | BMI z-score (approximate percentile)b | P-valuec | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
−1.5 (7th) |
−1.0 (16th) |
−0.5 (31st) |
0 (50th) |
0.5 (69th) |
1.0 (84th) |
1.5 (93rd) |
|||||||||||
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | HR | 95% CI | HR | 95% CI | HR | 95% CI | |||||
No censoring | 7 | 131 120 | 572 | 0.96 | 0.78–1.18 | 0.92 | 0.82–1.04 | 0.93 | 0.84–1.02 | 1.00 (ref.) | 1.08 | 0.98–1.20 | 1.26 | 1.11–1.41 | 1.52 | 1.27–1.81 | 0.05 |
8 | 132 493 | 583 | 0.97 | 0.77–1.22 | 0.93 | 0.82–1.06 | 0.93 | 0.84–1.03 | 1.00 (ref.) | 1.07 | 0.97–1.19 | 1.27 | 1.13–1.43 | 1.60 | 1.34–1.90 | 0.02 | |
9 | 127 482 | 583 | 0.93 | 0.73–1.19 | 0.93 | 0.81–1.05 | 0.94 | 0.85–1.04 | 1.00 (ref.) | 1.06 | 0.96–1.18 | 1.27 | 1.13–1.43 | 1.64 | 1.37–1.95 | 0.02 | |
10 | 123 940 | 578 | 0.97 | 0.77–1.24 | 0.90 | 0.79–1.02 | 0.89 | 0.80–0.98 | 1.00 (ref.) | 1.13 | 1.02–1.25 | 1.35 | 1.20–1.52 | 1.67 | 1.39–2.01 | 0.02 | |
11 | 123 007 | 580 | 0.95 | 0.75–1.22 | 0.90 | 0.79–1.03 | 0.91 | 0.82–1.00 | 1.00 (ref.) | 1.10 | 1.00–1.22 | 1.33 | 1.18–1.50 | 1.70 | 1.41–2.04 | 0.02 | |
12 | 121 950 | 578 | 0.88 | 0.68–1.13 | 0.86 | 0.75–0.98 | 0.88 | 0.80–0.98 | 1.00 (ref.) | 1.13 | 1.02–1.25 | 1.34 | 1.18–1.51 | 1.62 | 1.34–1.96 | 0.14 | |
13 | 120 133 | 566 | 0.85 | 0.66–1.10 | 0.83 | 0.73–0.95 | 0.86 | 0.78–0.96 | 1.00 (ref.) | 1.16 | 1.04–1.28 | 1.34 | 1.18–1.51 | 1.55 | 1.29–1.88 | 0.27 | |
Censored | 7 | 131 120 | 501 | 0.96 | 0.76–1.20 | 0.91 | 0.80–1.04 | 0.91 | 0.82–1.01 | 1.00 (ref.) | 1.10 | 0.99–1.23 | 1.31 | 1.16–1.49 | 1.64 | 1.37–1.97 | 0.02 |
8 | 132 493 | 512 | 0.91 | 0.71–1.18 | 0.90 | 0.79–1.03 | 0.92 | 0.83–1.02 | 1.00 (ref.) | 1.09 | 0.98–1.21 | 1.31 | 1.15–1.48 | 1.66 | 1.39–1.99 | 0.04 | |
9 | 127 482 | 512 | 0.88 | 0.67–1.15 | 0.90 | 0.78–1.04 | 0.94 | 0.84–1.05 | 1.00 (ref.) | 1.07 | 0.96–1.19 | 1.30 | 1.14–1.47 | 1.70 | 1.42–2.05 | 0.03 | |
10 | 123 940 | 508 | 0.97 | 0.75–1.25 | 0.89 | 0.77–1.02 | 0.88 | 0.79–0.98 | 1.00 (ref.) | 1.14 | 1.02–1.27 | 1.39 | 1.22–1.58 | 1.77 | 1.46–2.14 | 0.01 | |
11 | 123 007 | 510 | 0.90 | 0.69–1.19 | 0.88 | 0.76–1.01 | 0.89 | 0.80–1.00 | 1.00 (ref.) | 1.12 | 1.00–1.25 | 1.37 | 1.21–1.56 | 1.78 | 1.47–2.15 | 0.04 | |
12 | 121 950 | 510 | 0.84 | 0.63–1.11 | 0.84 | 0.73–0.97 | 0.88 | 0.79–0.98 | 1.00 (ref.) | 1.14 | 1.02–1.27 | 1.38 | 1.21–1.56 | 1.72 | 1.41–2.09 | 0.16 | |
13 | 120 133 | 498 | 0.82 | 0.62–1.09 | 0.81 | 0.70–0.93 | 0.85 | 0.76–0.95 | 1.00 (ref.) | 1.18 | 1.05–1.31 | 1.38 | 1.21–1.58 | 1.63 | 1.34–1.98 | 0.31 |
Abbreviations: BMI, body mass index; CI, confidence interval; HR, hazard ratio; HRT, hormone replacement therapy.
Cox model stratified by 5-year birth cohorts. BMI was modelled using linear splines with two knots at z-scores of ±0.68.
The exact percentile equivalents to the z-scores change with age, so approximate percentiles are shown.
Test for linearity using a likelihood ratio test.